Centers for Disease Control, FDA & Medicaid/Medicare Services
Introduction The human immunodeficiency virus (HIV) continues to impact millions of lives in the United States. Over sixty fiver percent of HIV diagnoses are African American individuals ages 13-24(Zanoni and Mayer, 2014). Additionally, 15-24-year-olds comprise 50% of recent HIV infection rates, which are 7-20 times higher among youth of color (CDC, 2013). The mortality rate among these groups is also higher(Fedeli et al., 2015). Currently, there is no medical treatment to cure HIV/AIDS, nor a vaccine for HIV contagion (Kurth, Celum, Baeten, Vermund, & Wasserheit, 2011). Thus making it very challenging for both community and public health leaders ...
